Section Arrow
TAOX.NASDAQ
- Tao Synergies Inc
Quotes are at least 15-min delayed:2026/09/25 19:32 EDT
After Hours
Last
 4.4887
+0.0587 (+1.33%)
Bid
4.34
Ask
4.51
High 4.5 
Low 4.35 
Volume 2.56K 
Regular Hours (Closed)
Last
 4.43
-0.04 (-0.89%)
Day High 
4.65 
Prev. Close
4.47 
1-M High
5.35 
Volume 
188.65K 
Bid
4.34
Ask
4.51
Day Low
4.25 
Open
4.65 
1-M Low
3.6 
Market Cap 
33.45M 
Currency 美元 
P/E 2.71 
%Yield -- 
10-SMA 4.19 
20-SMA 4.07 
50-SMA 3.75 
52-W High 10 
52-W Low 3.065 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.65/-7.44
Enterprise Value
33.45M
Balance Sheet
Book Value Per Share
1.70
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
299.06K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AXGSolowin Holdings Limited0.2-1.1-84.62%-- 
After Hours 0.1643 -0.0357 -17.85%
IRENIREN Limited44.125-2.025-4.39%52.64PE
After Hours 44.15 +0.025 +0.06%
MARAMARA Holdings Inc12.55-0.37-2.86%-- 
After Hours 12.5385 -0.0115 -0.09%
BMNRBitMine Immersion Technologies Inc.27.56-0.47-1.68%-- 
After Hours 27.57 +0.01 +0.04%
PURRHyperliquid Strategies Inc12.85-1.24-8.80%4.39PE
After Hours 12.83 -0.02 -0.16%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitiveconditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.